Abstract
Septic arthritis is frequently observed especially in immune-compromised or chronically diseased patients and leads to functional impairment due to tissue destruction. Recently, production of antimicrobial peptides (AMP) was observed in articular cartilage after exposure to bacteria. This report examines the role of synoviocyte-derived AMPs in innate defense mechanisms of articular joints. Samples of healthy, low-grade synovialitis and septic synovial membranes were assessed for the expression of human β-defensin-2 (HBD-2) and Toll-like receptor-2 and -4 (TLR) by immunohistochemistry and enzyme-linked immunosorbent assay (ELISA). A stable synoviocyte line (K4IM) was used for in vitro experiments and assayed for endogenous HBD-2 and TLR production after exposure to inflammatory cytokines or bacterial supernatants by reverse transcription polymerase chain reaction (RT-PCR), real-time RT-PCR, Western blot, ELISA, and dual luciferase assay. Healthy human synovial membranes and cultured synoviocytes are able to produce HBD-2 and TLR-1–5 at basal expression levels. Samples of bacteria-colonized synovial membranes produce higher levels of HBD-2 when compared with samples of healthy tissues. K4IM synoviocytes exposed to Staphylococcus aureus, Pseudomonas aeruginosa, or proinflammatory cytokines demonstrated a clear HBD-2 transcription and protein induction. TLR-2 and -4 are known to have a critical role in the recognition of gram-positive and gram-negative bacteria in epithelia and are induced in mesenchymal synoviocytes after bacterial exposure on transcription and on protein level. This report demonstrates an unappreciated role of synovial membranes: samples of septic synovial membranes and cultured synoviocytes exposed to bacteria produce increased amounts of the AMP HBD-2 and the bacteria recognition receptors TLR-2 and -4. The induction of anti-inflammatory pathways in infected synoviocytes suggests involvement in intra-articular defense mechanisms.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Septic arthritis frequently results from hematogenous spread of bacteria or traumatic or surgical bacterial contamination. The most common isolated bacteria in this case are Staphylococcus aureus [1, 2]. Once the bacteria invade the synovial membrane, bacterial toxins stimulate the release of multiple cytokines such as tumor necrosis factor (TNF-α) or interleukin-1 (IL-1). These cytokines, in turn, induce the production of proteolytic enzymes in synovial membrane and support the destruction of articular cartilage [3–5].
In general, the synovium consists of a thin lining layer of macrophages and fibroblasts [6, 7]. In healthy organisms, the predominant cell type is of mesenchymal origin and demonstrates fibroblast-like features [8, 9]. In pyogenic arthritis, the synovial lining thickens, and the sublining tissue becomes infiltrated with T cells, B cells, and macrophages.
The host response to bacterial infection is dependent on both innate (non-antibody-mediated) and adaptive (antibody-mediated) immune systems. The adaptive immune system is primarily cellular in composition and relies on the actions of B and T cells. The innate immune response is more immediate and depends on the activity of phagocytic cells and the expression of a number of antimicrobial proteins and peptides (AMP) [10, 11]. Defensins are an important subfamily of AMP and are able to kill microbes by destructing their cell membranes. To date, six human β-defensin (HBDs), HBD-1 through -6, have been identified in human tissues [10, 11]. The HBDs differ in tissue distribution and expression profile after stimulation with proinflammatory cytokines or bacteria [12–16]. The HBD-2 was first isolated from human skin and displays potent antimicrobial activity in the gram-negative and -positive range as well [12]. The importance of AMP in host defense becomes evident in mice overexpressing the human alpha-defensin-5 gene and the subsequent resistance to oral application of Salmonella typhimurium [17]. Other studies revealed that mice with disrupted AMP genes are prone to infection in the affected organs [18].
Toll-like receptors (TLR) are a family of transmembrane receptors [19–21]. They were regarded as key regulators of both innate and adaptive immune response and recognize pathogen-associated molecular patterns (PAMPs) from gram-positive and -negative bacteria [22]. The interaction of TLRs with PAMPs results in the nuclear translocation of the transcription factor nuclear factor kappa B (NF-κB) and a subsequent increase of AMP production [9, 10, 23]. Studies on epithelia demonstrate that TLR-4 and its accessory molecule lymphocyte antigen 96 (MD-2) are required for the recognition of lipopolysaccharide found in the membranes of gram-negative bacteria [24]. By contrast, TLR-2 is required for the recognition of bacterial lipopeptide, and in combination with TLR-6, for the detection of peptidoglycan and lipoteichoic acid, which are components of gram-positive bacteria [23]. Up to now, reports are missing concerning the expression and regulation of TLRs in mesenchymal synoviocytes in case of bacterial exposure.
Recent studies of our group have demonstrated that synovial membranes have the ability to produce HBDs in case of inflammatory or bacterial joint disease [25, 26]. Moreover, expression pattern of these peptide antibiotics changed, dependent on the kind of joint disease, thus, suggesting a regulative AMP production after being challenged by inflammatory mediators [26].
The aim of the current study was to determine inflammatory production and regulation of HBD-2 in human synovial membranes and to evaluate the findings in an in vitro model with immortalized synoviocytes called K4IM and primary synoviocytes.
Material and methods
Tissues
Healthy synovial membranes (n = 6) were collected from knee joints without signs of degeneration. The articular joints were dissected from body donors, donated to the Institute of Anatomy. Infected synovial membranes (high-grade synovialitis; n = 6) and low-grade synovialitis synovial membrane (n = 6) were collected from patients who underwent revision surgery due to bacterial infection at the Department of Trauma, University of Kiel. All samples from patients suffering from septic arthritis showed positive microbiological cultures for gram-positive bacteria such as S. aureus (n = 3) or S. epidermidis (n = 3). The study was approved by the institutional review board.
Human cell culture
To analyze parameters that lead to the activation of synovial fibroblasts, we cultured a stable human synoviocyte line (K4IM, a generous gift from Christian Kaps, Charite, Berlin, Germany) which is immortalized with the SV40 T antigen [27]. Several studies confirmed that the immortalized K4IM cell line represents a valuable tool to study mechanisms that induce synoviocyte activation [27, 28]. For Western blot analysis, primary synoviocytes were collected from healthy synovial membranes of body donors and prepared for in vitro examinations, as recently described by Ralph et al. [29]. For in vitro experiments, synoviocytes were cultured in monolayers in RPMI-1640 media supplemented with 10% (v/v) fetal calf serum, 2 mM glutamine, and 50 μg/ml penicillin-streptomycin (Gibco BRL). At 80% confluency, stimulation experiments were performed in serum-free RPMI-1640 medium in humidified 5% CO2 atmosphere.
Stimulants
Synoviocytes in monolayer culture were exposed to IL-1/-6 (10 ng/ml), TNF-α (10 ng/ml) or supernatants of Pseudomonas aeruginosa (PAS) or S. aureus (diluted 1:50) for 6 or 24 h. The supernatants were generated from clinical isolates, as recently described by Gläser et al. [30].
RNA preparation and cDNA synthesis
Frozen tissue samples (20 mg) of healthy and infected synovial membranes were crushed in an achate mortar under liquid nitrogen. RNA from tissues was generated by Trizol reagent. Moreover, RNA from cultured synoviocytes was extracted with the RNeasy Total RNA kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Contaminating DNA was destroyed by digestion with RNase-free DNase-I (20 min at 25°C, Boehringer, Mannheim, Germany). After inactivation of DNase (15 min at 65°C), complementary DNA (cDNA) was generated with 1 μl (20 pmol) of oligo (dt) primer (Amersham Pharmacia, Uppsala, Sweden) and 0.8 μl of superscript RNase H-reverse transcriptase (Gibco, Paisley, UK) for 60 min at 37°C.
Reverse transcription polymerase chain reaction
For PCR, 4 µl of cDNA were incubated with 30.5 µl water, 4 µl 25 mM MgCl2, 1 µl dNTP, 5 µl 10 × PCR buffer, and 0.5 µl (2.5 U) platinum Taq DNA polymerase (Gibco), and the following pairs of primers: HBD-2-for1 5′-CCAGCCATCAGCCATGAGGGT-3′, HBD-2-ra 5′-GGAGCCCTTTCTGAATCCGCA-3′, 57°C, 255 bp; TLR-1-for1 5′-CTATACACCAAGTTGTCAGC-3′, TLR-1-ra 5′-GTCTCCAACTCAGTAAGGTG-3′, 56°C, 210 bp; TLR-2-for1 5′-GCCAAAGTCTTGATTGATTGG-3′, TLR-2-ra 5′-TTGAAGTTCTCCAGCTCCTG-3′, 56°C, 347 bp; TLR-3-for1 5′-GATCTGTCTCATAATGGCTTG-3′, TLR-3-ra 5′-GACAGATTCCGAATGCTTGTG-3′, 56°C, 300 bp; TLR-4-for1 5′-TGGATACGTTTCCTTATAAG-3′, TLR-4-ra 5′-GAAATGGAGGCACCCCTTC-3′, 56°C, 548 bp; TLR-5-for1 5′-CTAGCTCCTAATCCTGATG-3′, TLR-5-ra 5′-CCATGTGAAGTCTTTGCTGC-3′, 56°C, 400 bp. A glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific intron-spanning primer pair (forward primer: 5′TGAAGGTCGGAGTCAACGGA TTTGGT-3′; reverse primer: 5′-CATGTGGGCCATGAGGTCCACCAC -3′), which yielded a 983-bp amplified product, served as the internal control for equal amounts of cDNA. Thirty-five cycles were performed with each primer pair. All primers were synthesized by MWG-Biotech AG, Ebersberg, Germany. For the negative control reaction, the cDNA was replaced with water.
Real-time reverse transcription polymerase chain reaction
Real-time reverse transcription polymerase chain reaction (RT-PCR) was carried out using a one-step RT-PCR system (Qiagen; QuantiTect SYBR Green RT-PCR). For this purpose, 100 ng of total RNA was added. Real-time RT-PCR was used to monitor gene expression using an i-Cycler (Biorad, München, Germany) according to the standard procedure. PCR was performed, as recently described by our group [31, 32]. I-Cycler Data Analysis software (Biorad, München, Germany) was used for PCR data analysis. The used TaqMan primers and probes had the following identification numbers: GAPDH: Hs99999905_m1, HBD-2: Hs00823638_m1, TLR-2: Hs00610101_m1, and TLR-4: Hs00370853_m1 (Applied Biosystems, Darmstadt, Germany). Relative quantification was performed by normalizing the signals of the different genes against those of GAPDH. The assessed data included three independent experiments with triplicates.
Western blot
For Western blots, samples were reduced in the presence of 10 mM dithiothreitol, proteins separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (10% gels), transferred onto nitrocellulose membranes that were blocked and incubated with antibodies according to standard techniques as described [33]. Signals were detected by chemiluminescence reaction (ECL-Pus; Amersham Pharmacia, Uppsala, Sweden).
HBD-2 enzyme-linked immunosorbent assay
For enzyme-linked immunosorbent assay (ELISA), 100 mg fresh weight of healthy and infected synovial membranes was crushed in an achate mortar under liquid nitrogen and homogenized in 150 mM NaCl, 20 mM Tris HCl buffer, pH 7.4, using a polytron homogenizer (Kinematica, Luzern, Switzerland). A soluble fraction was obtained by centrifugation at 48.000 × g for 60 min. Subsequently, 50 µl aliquots of this homogenates and aliquots of the collected cell supernatants from the stimulation experiments were examined by sandwich ELISA. Ninety-six well immunoplates (MaxiSorp™, Nunc, Roskilde, Denmark) were coated at 4°C for 24 h with 100 µl (0.5 µg/ml) goat anti-HBD-2 antibody (Acris, Hiddenhausen, Germany; PP1125P2) diluted 1:500 in 0.05 M carbonate buffer, pH 9.6. Subsequently, wells were blocked with 200 µl 1% bovine serum albumin in phosphate buffer solution (PBS) for 10 min at room temperature. After three times washing with 200 µl PBS + 0.1% Tween 20, 100 µl per well of cell culture supernatants were incubated for 30 min at room temperature. Plates were washed thrice with PBS + 0.1% Tween 20, and wells were incubated for 30 min at room temperature with 50 µl of biotinylated goat anti-HBD-2 antibody (Acris, Hiddenhausen, Germany, PP1125B1) diluted 1:2.500 to 0.2 µg/ml in PBS + 0.1% Tween 20. Plates were washed again three times with PBS + 0.1% Tween and filled with 50 µl/well of streptavidin-POD (Roche Diagnostics, Mannheim, Germany; 1:10.000 in PBS + 0.1% Tween 20). The plates were then incubated for 30 min at room temperature, washed three times as described above, and incubated with 2.2′-azino-bis-3-ethylbenzthiazoline-6-sulfonic acid (Roche Diagnostics) as the development agent for 15–45 min at room temperature in the dark. Absorbance was measured at 405 nm with a multichannel photometer (Sunrise; Tecan, Crailsheim, Germany). Human recombinant HBD-2 (PeproTec, Rocky Hill, CT, USA) served as the standard with the following concentrations: 0, 0.16, 0.32, 0.64, 1.25, 2.5, and 5 ng/ml.
Dual luciferase assay
The luciferase assay was carried out as described in Harder et al. [34].
Statistical analysis
Differences between the groups were evaluated using the t test. Group differences were considered significant if P < 0.05. All statistical analyses were carried out using the JMP statistics package (SAS Institute, Cary, NC, USA).
Results
Human β-defensin-2 is induced in septic synovial membrane
To evaluate HBD-2 expression in low-grade synovialitis and in healthy and inflamed human synovial membranes (high-grade synovialitis), RT, PCR, immunohistochemistry, and ELISA experiments were performed.
RT-PCR revealed HBD-2 transcripts in all examined tissue samples of bacteria-infected synovial membranes (Fig. 1a). Immunohistochemistry was used to analyze expression pattern of HBD-2 in healthy and infected tissues. Neglectable immunostaining was demonstrated in tissue samples of low-grade synovialitis or healthy synovial membranes (Fig. 1b), but bacterial colonization results in a significant upregulation of HBD-2. The observed immunostaining was primarily visible in the extracellular matrix of fibroblasts, as detected by their characteristic shape (Fig. 1b).
ELISA experiments were performed to analyze quantitative amounts of HBD-2 protein in the collected tissue samples of healthy, low-grade synovialitis and high-grade synovialitis (bacteria-infected synovial membranes). In case of gram-positive infections, HBD-2 expression levels clearly raised to 1.5 ng/100 mg fresh tissue, thus demonstrating a microbial influence in the regulation of synovial membrane-derived AMP (Fig. 1c). The amount of HBD-2 in healthy and in low-grade synovialitis was similar (Fig. 1c).
IL-1, IL-6, TNF-α, P. aeruginosa, and S. aureus stimulate HBD-2 expression in cultured synoviocytes
To assess inducers of HBD-2 in synovial membranes, K4IM synoviocytes were taken into cell culture and stimulated with different proinflammatory cytokines and supernatants of a clinical isolate of S. aureus or P. aeruginosa. After 6 or 24 h of stimulation, RNA or cell supernatants were collected and assayed by RT-PCR, real-time RT-PCR, or ELISA experiments. Similar to recent results in chondrocytes, cultured K4IM synoviocytes strongly induce HBD-2 transcripts after exposure to IL-1/-6 or TNF-α (Fig. 2a, b). Among these inflammatory cytokines, TNF-α has the greatest impact on HBD-2 gene expression in K4IM cells (Fig. 2b). Protein analysis with a HBD-2 sandwich ELISA revealed gram-positive bacteria of S. aureus and gram-negative P. aeruginosa as additional stimulators, because 24 h after exposure amounts of secreted HBD-2 protein raised up to 160 ng/300.000 cells. Interestingly, induction of HBD-2 was not dependent on the specification of the bacteria and did not exceed amounts of cytokine-exposed synoviocytes (Fig. 2c).
The Toll-like receptors 1–5 are expressed in healthy synovial membranes
To investigate the expression of TLRs, which are known to be involved in the regulation of AMPs in epithelia, RT-PCR, immunohistochemistry, and Western blot investigations were performed. RT-PCR revealed transcripts of TLR-1–5 in homogenates of healthy synovial membranes (Fig. 3), indicating a role in the regulation of AMP in mesenchymal synovial membranes. Because of their key role in bacteria-mediated anti-inflammatory pathways in epithelia, production of TLR-2 and -4 was additionally demonstrated by immunohistochemistry in samples of septic synovial membranes (Fig. 1b). Regulation of TLR-4 was examined in primary synoviocytes after exposure to P. aeruginosa. Western blot analysis revealed induction of gram-negative specialized TLR-4 after 24 h of bacterial stimulation.
Bacterial induction of TLR-2 and -4 in cultured synoviocytes
To test the inducibility of TLR-2 and -4 in cultured synoviocytes, K4IM cells were challenged by TNF-α or supernatants of P. aeruginosa and S. aureus. After 6 h of co-culturing, RT-PCR and real-time RT-PCR examinations were performed. Addition of the proinflammatory cytokine TNF-α (10 ng/ml) resulted in an increased transcription of TLR-4 (Fig. 4a). Real-time RT-PCR demonstrated a clear induction of TLR-2 and -4-messenger RNA after 6 h of exposure to gram-negative P. aeruginosa and gram-positive S. aureus (Fig. 4b). Interestingly, bacterial specification did not significantly influence TLR-2 gene expression, but quantitative TLR-4-RT-PCR revealed more transcripts in case of gram-positive bacterial stimulation with S. aureus (Fig. 4b).
Proinflammatory cytokines and supernatant of P. aeruginosa and S. aureus increase promoter activity of HBD-2
In order to verify the ELISA and real-time RT-PCR data, we performed dual luciferase assays. IL-1 leads to an 11-fold, TNF-α to an eightfold, and IL-6 to a twofold increase of the HBD-2 promoter activity (Fig. 5a). P. aeruginosa leads to a 1.2-fold and S. aureus to a 2.2-fold increase of the HBD-2 promoter activity (Fig. 5b). After 12 h, 10 ng/ml IL-1 leads to a maximum of HBD-2 promoter activity (Fig. 5c; control = 1). All experiments were performed with n = 8.
Discussion
Defensins are an essential part of the host innate immune system responsible for the first line of defense against pathogenic microorganisms [10, 11]. In case of bacterial arthritis, many cell types neighboring to synoviocytes (for instance chondrocytes, osteocytes, and osteoblasts) were affected, but Typ-A and -B-synoviocytes were regarded as the most immunocompetent cells from all. Therefore, we analyzed the production and regulation of the antimicrobial peptide HBD-2 in samples of healthy and infected synovial membranes and evaluated these findings in a model of cultured K4IM synoviocytes after inflammatory or bacterial exposure.
The transcriptional induction of HBD-2 in mesenchymal synovial membrane after contact with proinflammatory cytokines or S. aureus is in accordance with previous results on epithelial tissues, which examine the antibacterial role of defensins. Harder et al. [12] were the first who describe the induction of HBD-2 after inflammatory challenge of human skin. Other studies confirmed upregulation in several epithelial tissues such as the lungs or the gastrointestinal or urogenital tract [13, 35–38]. Typical stimulators include the cytokines TNF-α, IL-1/-6, or the gram-negative bacteria P. aeruginosa [12, 34, 38, 39]. Many studies failed to observe HBD-2 induction following gram-positive bacterial stimulation, but it is reasonable to propose that AMP induction differs dependent on the examined tissues and the pathogenicity of the used bacteria [12, 39].
The induction of synoviocyte-secreted HBD-2 protein was measured after 24 h of inflammatory or bacterial stimulation. In contrast, AMP secretion of blood cells is induced within a few minutes as a result of storage in cellular granules. The continuous expression of HBD-2 from synoviocytes after inflammatory challenge seems to be more likely a result of a de novo synthesis [10, 11]. Only two studies have already focused on the expression and regulation of HBD-2 in mesenchymal tissues such as articular cartilage or synovial membranes [26, 32]. Paulsen et al. discovered HBD-2 only in situ in some samples of pyogenic synovial membranes by means of immunohistochemistry [26]. In contrast to our study, all examined tissue samples were tested positive for S. aureus colonization and thus may explain their observed incontinuous production of HBD-2.
The induction of HBD-2 in synovial membrane is not merely connected with antibacterial tasks. The secreted protein levels, as measured by ELISA, were at low antibacterial levels, but concomitant expression of cartilage- or neutrophil-released AMPs may increase intra-articular defense levels. In addition to their antimicrobial activity, HBD-2 provides a link to the adaptive immune system by attracting immature dendritic cells and memory T cells via the chemokine receptor CCR-6 [40]. Interestingly, for chemotactic tasks, HBD-2 is needed in much lower concentrations. Recently, two reports describe intra-articular accumulation of AMPs in human joints following abacterial rheumatoid arthritis (RA) [41, 42]. Without immediate threat of bacterial colonization, bactericidal/permeability-increasing protein (BPI) and human neutrophil peptides (HNP-1–3) increased in joint fluid samples of patients with RA. Moreover, they observed a significant correlation between joint destruction and intra-articular accumulation of BPI and HNP, thus suggesting additional tasks of AMPs than the antimicrobial [42]. Previous results of our group may provide an explanation. After co-incubation of chondrocytes or cartilage discs with HBD-3 protein, levels of tissue destructive matrix metalloproteinases raises, and levels of their endogenous inhibitors (tissue inhibitors of metalloproteinases) dropped [31]. Especially, the observed sub-antimicrobial protein levels support our hypothesis that synoviocyte-derived HBD-2 expression following inflammatory exposure may modify migration pattern of blood cells into the joint cavity via CCR-6 receptor or interferes with tissue remodeling processes in articular cartilage.
The receptor, which mediates bacteria- or inflammatory-dependent upregulation of AMP in infectious arthritis, has not yet been characterized. The induction of TLR-2 and -4 in cultured synoviocytes suggest a possible involvement in host AMP production following bacterial stimulation. TLR recognize specific pathogen-associated molecules that are associated with a variety of bacteria, viruses, and fungi [21–23]. Interaction of TLR and bacterial pathogens resulted in an enhanced production of antimicrobial proteins and secretion of proinflammatory cytokines in epithelial tissues, but the role of TLRs in bacteria-infected mesenchymal tissues has to be evaluated in future experiments [21].
Conclusion
Taken together, this is the first report which describes the induction of HBD-2 and the PAMP receptors TLR-2 and -4 in synovial membranes after inflammatory and bacterial exposure and suggests involvement either in innate defense mechanism or in the regulation of the destructive course of septic arthritis.
References
Goldenberg DL (1999) Septic arthritis. Lancet 351:197–202
Ross JJ (2005) Septic arthritis. Infect Dis Clin North Am 4:799–817
Jasin HE (1983) Bacterial lipopolysaccharides induce in-vitro degradation of cartilage matrix through chondrocyte activation. J Clin Invest 72:2014–2019
Deng GM, Verdrengh M, Liu ZQ et al (2000) The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs. Arthritis Rheum 43:2283–2289
Hsieh YS, Yang SF, Lue KH et al (2006) Clinical correlation with the PA/plasmin system in septic arthritis of the knee. Clin Orthop Relat Res 447:172–178
Castor CW (1960) The microscopic structure of normal human synovial tissue. Arthritis Rheum 3:140–151
Barland P, Novikoff AB, Hamerman D (1962) Electron microscopy of the human synovial membrane. J Cell Biol 14:207–220
Wilkinson LS, Pitsillides AA, Worrall JG et al (1992) Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte). Arthritis Rheum 35:1179–1184
Stevens CR, Mapp PI, Revell PA (1990) A monoclonal antibody (Mab 67) marks type B synoviocytes. Rheumatol Int 10:103–106
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395
Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710–720
Harder J, Bartels J, Christophers E et al (1997) A peptide antibiotic from human skin. Nature 387:861
Valore EV, Park CH, Quale AJ et al (1998) Human β-defensin-1: an antimicrobial peptide of urogenital tissue. J Clin Invest 101:1633–1642
Harder J, Bartels J, Christophers E et al (2001) Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707–5713
Garcia JR, Krause A, Schulz S et al (2001) Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 15:1819–1821
Garcia JR, Jaumann F, Schulz S et al (2001) Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 306:257–264
Salzman NH, Ghosh D, Huttner KM et al (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522–526
Nizet V, Ohtake T, Lauth X et al (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454–457
Muzio M, Polentarutti N, Bosisio D et al (2000) Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J Leukoc Biol 67:450–455
Mushegian A, Medzhitov R (2001) Evolutionary perspective on innate immune recognition. J Cell Biol 155:705–711
Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675–678
Cook DN, Pisetsky DS, Schwartz DA (2004) Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5:975–979
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376
Suzuki M, Hisamatsu T, Podolsky K (2003) Y interferon augments intracellular pathway for LPS recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular TLR-4-MD-2 complex. Infect Immun 71:3503–3511
Paulsen F, Pufe T, Petersen W et al (2001) Expression of natural peptide antibiotics in human articular cartilage and synovial membrane. Clin Diagn Lab Immunol 8:1021–1023
Paulsen F, Pufe T, Conradi L et al (2002) Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J Pathol 198:369–377
Haas C, Aicher WK, Dinkel A et al (1997) Characterization of SV40T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-1, HLA-DR and some surface receptors. Rheumatol Int 16:241–247
Hess S, Rheinheimer C, Tidow F et al (2001) The reprogrammed host: Chlamydia trachomatis-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptotic genes. Arthritis Rheum 44:2392–2401
Ralph JA, McEvoy AN, Kane D et al (2005) Modulation of orphan nuclear receptor NURR1 expression by methotrexate in human inflammatory joint disease involves adenosine A2A receptor-mediated responses. J Immunol 175:555–565
Gläser R, Harder J, Lange H et al (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 1:57–64
Varoga D, Pufe T, Harder J et al (2005) Human β-defensin-3 mediates tissue remodelling processes in articular cartilage by increasing metalloproteinases and reducing their endogenous inhibitors. Arthritis Rheum 52:1736–1745
Varoga D, Paulsen FP, Kohrs S et al (2006) Expression and regulation of human beta-defensin-2 in osteoarthritis. J Pathol 209:166–173
Pufe T, Petersen W, Tillmann B et al (2001) The angiogenic peptide vascular endothelial growth factor is expressed in foetal and ruptured tendons. Virchows Arch 439:579–585
Harder J, Meyer-Hoffert U, Teran LM et al (2000) Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1-beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 22:714–721
Liu L, Roberts AA, Ganz T (2003) By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 170:575–580
Bals R, Wang X, Wu Z et al (1998) Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102:874–880
Becker MN, Diamond G, Verghese MW et al (2000) CD-14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 275:29731–29736
O’Neil DA, Porter EM, Elewaut D et al (1999) Expression and regulation of the human beta-defen-sins hBD-1 and HBD-2 in intestinal epithelium. J Immunol 163:6718–6724
Varoga D, Pufe T, Harder J et al (2004) Production of endogenous antibiotics in articular cartilage. Arthritis Rheum 50:3526–3534
Yang D, Chertov O, Bykovskaia SN et al (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525–528
Punzi L, Peuravuori H, Jokilammi-Siltanen A et al (2000) Bactericidal/permeability increasing protein and proinflammatory cytokines in synovial fluid of psoriatic arthritis. Clin Exp Rheumatol 18:613–615
Bokarewa MI, Jin T, Tarkowski A (2003) Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis. J Rheumatol 30:1719–1724
Acknowledgments
We wish to thank Susanne Echterhagen, Christiane Jaeschke, Patrycja Kozak, Inka Kronenbitter, Ursula Mundt, Michaela Nicolau, Angela Rüben, Sonja Seiter, and Kirsten Vosen for their expert technical assistance and Clemens Franke for the drawing. The K4IM and the HSE cells were a courtesy from Christian Kaps. This work was supported by grants of the Deutsche Forschungsgemeinschaft (SFB 617, project A22; DFG Va 220/2-1, Pu 214/3-2, Pu 214/4-2, Pu 214/5-2, and PA 738/9-1), from the “Stiftung zur Förderung der Medizinischen Forschung” of the Medical Faculty of the University of Kiel (to D V and TP), from the Hensel Stiftung (to DV and FP), and by the “Verein zur Förderung der Erforschung und Bekämpfung rheumatischer Erkrankungen Bad Bramstedt e.V.”, and by BMBF/Wilhelm-Roux (FKZ 9/16 to FP).
Conflicts of interest
We declare that we have no conflict of interest.
Authors’ contributions
DV, TP, EK, CW, LB, FP, MT, and SL performed the experiments, and BT and AS contributed to the draft manuscript; DV and TP contributed equally to the present work. The manuscript has been read and approved by all authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
The experiments comply with the current laws of Germany.
Rights and permissions
About this article
Cite this article
Varoga, D., Klostermeier, E., Paulsen, F. et al. The antimicrobial peptide HBD-2 and the Toll-like receptors-2 and -4 are induced in synovial membranes in case of septic arthritis. Virchows Arch 454, 685–694 (2009). https://doi.org/10.1007/s00428-009-0780-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-009-0780-4